Volume 15 Number 8
31 August 2015

Home > Publications > Current Neuro-Oncology > Volume 17, Year 2015 > Number 8, 31 August

Blüml S, Margol AS, Sposto R, Kennedy RJ, Robison NJ, Vali M, Hung LT, Muthugounder S, Finlay JL, Erdreich-Epstein A, Gilles FH, Judkins AR, Krieger MD, Dhall G, Nelson MD, Asgharzadeh S.
Molecular subgroups of medulloblastoma identification using noninvasive magnetic resonance spectroscopy.

Neuro Oncol. 2015 Aug 8. 2016;18(1):126-31. doi: 10.1093/neuonc/nov097. Similar articles. Laboratory investigation. _

Vivekanandan S, Breene R, Ramanujachar R, Traunecker H, Pizer B, Gaze MN, Saran F, Thorp N, English M, Wheeler KA, Michalski A, Walker DA, Saunders D, Cowie F, Cameron A, Picton SV, Parashar D, Horan G, Williams MV.
The UK Experience of a Treatment Strategy for Pediatric Metastatic Medulloblastoma Comprising Intensive Induction Chemotherapy, Hyperfractionated Accelerated Radiotherapy and Response Directed High Dose Myeloablative Chemotherapy or Maintenance Chemotherapy (Milan Strategy).
Pediatr Blood Cancer. 2015 Aug 14, 2015;62(12):2132-9🡥. doi: 10.1002/pbc.25663🡥. PMID: 26274622🡥. Observational study. 🡥

Wu CX, Lin GS, Lin ZX, Zhang JD, Chen L, Liu SY, Tang WL, Qiu XX, Zhou CF.
Peritumoral edema on magnetic resonance imaging predicts a poor clinical outcome in malignant glioma.
Oncol Lett. 2015 Aug 25. 2015;10(5):2769-2776. doi: 10.3892/ol.2015.3639. Observational study. _

Wenger C, Giladi M, Bomzon Z, Salvador R, Basser PJ, Miranda PC.
Modeling Tumor Treating Fields (TTFields) application in single cells during metaphase and telophase.
Conf Proc IEEE Eng Med Biol Soc. 2015 Aug 25-29;2015:6892-5🡥. doi: 10.1109/EMBC.2015.7319977🡥. PMID: 26737877🡥 Laboratory investigation. _